Diseases such as tuberculosis, anthrax, and shigellosis -- a severe food-borne illness -- eventually could be treated with an entirely new and more-effective kind of antibiotic, thanks to a team of scientists led by Kenneth Keiler, an associate professor of biochemistry and molecular biology at Penn State University. In a research paper that will be published in the journal Proceedings of the National Academy of Sciences during the week beginning 3 June 2013, the team describes 46 previously untested molecules that target and disrupt an important step in the process of protein synthesis in bacteria, thereby rendering bacteria incapable of replicating.

“The name of my village is Nimdaha.”

Now Eastern European and Central Asian Community Advisory Board (EECA CAB), a joint initiative of ITPCru and ECUO, has a website: www.eeca-cab.org/en.

How is it that the wealthiest country on Earth could be forced to resort to a Third World solution to treat a disease as dangerous as TB?

The report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda identified tuberculosis investments as highly cost-effective and proposed a specific sub-target on TB as part of a set of goals that could be used to guide development for the 15 years after 2015.

Abstract

It still takes a long time for TB and HIV patients in Uganda to be properly diagnosed. As a result, many patients are infectious without knowing it themselves. These diagnostic delays, and also adherence to therapy, can be explained by a combination of social and health care related factors, such as a lack of awareness about the diseases, the sex of a patient and socioeconomic status. This is one of the conclusions of the PhD research of Ibrahim Sendagire.

The Global Health Innovative Technology Fund (GHIT Fund), a new public-private partnership that’s bringing Japanese research and development (R&D) to the global fight against infectious disease, will announce at the 5th Tokyo International Conference on African Development (TICAD V) a series of historic agreements to screen compound libraries at Japanese pharmaceutical companies and research institutes for new treatments for malaria, tuberculosis, and other afflictions that prey mainly on the poorest of the poor.

30 May 2013 - Addis Ababa, Ethiopia - Community health workers - known as health extension workers in Ethiopia - have teamed up with motorbike riders to dramatic effort in Ethiopia’s Sidama Zone, finding double the number of people with tuberculosis (TB) compared to a previous period and increasing their chances of survival.

During their first year of antiretroviral therapy (ART), migrants in Europe, the United States, and Canada had a 20% higher rate of new AIDS-defining events than nonmigrants, according to results of a 48,854-person analysis. But migrants did not have a higher death rate in the first year of ART.